191 related articles for article (PubMed ID: 33369003)
1. Antiallergic drug desloratadine as a selective antagonist of 5HT
Lu J; Zhang C; Lv J; Zhu X; Jiang X; Lu W; Lu Y; Tang Z; Wang J; Shen X
Aging Cell; 2021 Jan; 20(1):e13286. PubMed ID: 33369003
[TBL] [Abstract][Full Text] [Related]
2. DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.
Lv J; Wang W; Zhu X; Xu X; Yan Q; Lu J; Shi X; Wang Z; Zhou J; Huang X; Wang J; Duan W; Shen X
Brain Behav Immun; 2020 Nov; 90():55-69. PubMed ID: 32739363
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
[TBL] [Abstract][Full Text] [Related]
4. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
DuBuske L
Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
[TBL] [Abstract][Full Text] [Related]
5. Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling.
Li L; Wu XH; Zhao XJ; Xu L; Pan CL; Zhang ZY
J Neuroinflammation; 2020 Feb; 17(1):61. PubMed ID: 32066466
[TBL] [Abstract][Full Text] [Related]
6. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
7. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
8. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
[TBL] [Abstract][Full Text] [Related]
10. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
Front Immunol; 2019; 10():2780. PubMed ID: 31849963
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.
Griciuc A; Federico AN; Natasan J; Forte AM; McGinty D; Nguyen H; Volak A; LeRoy S; Gandhi S; Lerner EP; Hudry E; Tanzi RE; Maguire CA
Hum Mol Genet; 2020 Oct; 29(17):2920-2935. PubMed ID: 32803224
[TBL] [Abstract][Full Text] [Related]
12. Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism.
Medrano-Jiménez E; Jiménez-Ferrer Carrillo I; Pedraza-Escalona M; Ramírez-Serrano CE; Álvarez-Arellano L; Cortés-Mendoza J; Herrera-Ruiz M; Jiménez-Ferrer E; Zamilpa A; Tortoriello J; Pedraza-Alva G; Pérez-Martínez L
J Neuroinflammation; 2019 Jul; 16(1):143. PubMed ID: 31291963
[TBL] [Abstract][Full Text] [Related]
13. Effects of antihistamines on innate immune responses to severe bacterial infection in mice.
Metz M; Doyle E; Bindslev-Jensen C; Watanabe T; Zuberbier T; Maurer M
Int Arch Allergy Immunol; 2011; 155(4):355-60. PubMed ID: 21346365
[TBL] [Abstract][Full Text] [Related]
14. Influenza vaccination in early Alzheimer's disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells.
Yang Y; He Z; Xing Z; Zuo Z; Yuan L; Wu Y; Jiang M; Qi F; Yao Z
J Neuroinflammation; 2020 Feb; 17(1):65. PubMed ID: 32075657
[TBL] [Abstract][Full Text] [Related]
15. EGb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse.
Wan W; Zhang C; Danielsen M; Li Q; Chen W; Chan Y; Li Y
Exp Gerontol; 2016 Aug; 81():92-100. PubMed ID: 27220811
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug.
Agrawal DK
Expert Opin Investig Drugs; 2001 Mar; 10(3):547-60. PubMed ID: 11424898
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
Meltzer EO; Gillman SA
Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
[TBL] [Abstract][Full Text] [Related]
18. Desloratadine: an update of its efficacy in the management of allergic disorders.
Murdoch D; Goa KL; Keam SJ
Drugs; 2003; 63(19):2051-77. PubMed ID: 12962522
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.
Wilken JA; Kane RL; Ellis AK; Rafeiro E; Briscoe MP; Sullivan CL; Day JH
Ann Allergy Asthma Immunol; 2003 Oct; 91(4):375-85. PubMed ID: 14582817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
